Tralokinumab is a biologic monoclonal antibody that targets specific proteins or receptors in the body, to regulate the immune response or interfere with disease processes. The liquid solution is injected subcutaneously with a pre-filled syringe to limit the overreaction of the immune system, dampening down inflammation and reducing itch.

Finacea contains azelaic acid, an antimicrobial that has a direct effect on follicular hyperkeratosis as a therapy for acne

Contains azelaic acid, which inhibits the growth of the Propionibacteria involved in the development of acne and the production of acne-promoting fatty acids. Azelaic acid also reduces the multiplication and keratinisation of keratinocytes, and therefore restricts the formation of comedones.

Fucidin contains fusidic acid, a potent antibacterial agent. Fusidic acid and its salts show fat and water solubility and strong surface activity, and exhibit an unusual ability to penetrate intact skin. Concentrations of 0.03–0.12mcg fusidic acid per ml inhibit nearly all strains of Staphylococcus aureus. Topical application is also effective against streptococci, corynebacteria, niesseria and certain clostridia

A water-miscible cream containing clobetasone 17-butyrate 0.05% w/w, oxytetracycline 3.0% w/w as calcium oxytetracycline and nystatin 100,000 units per gram.

Fragrance-free, non-greasy, viscous skin protectant containing dimethicone. Protects against moisture-associated skin damage related to incontinence.

An emollient containing 30% emulsifying wax and 30% yellow soft paraffin

White soft paraffin 13.2% and liquid paraffin light 10.5% cream

An emollient containing white soft paraffin and liquid paraffin, to help the skin retain more moisture

Moisturising cream with ingredients including white soft paraffin 13.2% w/w and light liquid paraffin 10.5% w/w.